Live from the NIH registry
Studies recruiting near Augusta right now
Top 25 of 182 recruiting studies, sorted by proximity — each links to its official registry page
Caris Biorepository Research Protocol
Cancer, Early Detection of Cancer
N/A
Observational 100,000 participants sought
Augusta University Research Institute — Augusta, Georgia (9.2 mi)
· Sponsor: Caris Science, Inc.
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation
Phase 1
Interventional 420 participants sought
Georgia Cancer Center at Augusta University — Augusta, Georgia (9.2 mi)
· Sponsor: Kura Oncology, Inc.
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi)
· Sponsor: NRG Oncology
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 2
Interventional 60 participants sought
Investigator Site #29 — Augusta, Georgia (9.2 mi)
· Sponsor: Akebia Therapeutics
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi)
· Sponsor: SWOG Cancer Research Network
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Phase 2, Phase 3
Interventional 201 participants sought
Augusta University — Augusta, Georgia (9.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Candidemia, Candidiasis, Invasive
Phase 3
Interventional 450 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi)
· Sponsor: Basilea Pharmaceutica
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
Phase 1, Phase 2
Interventional 100 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi)
· Sponsor: Atavistik Bio, Inc
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi)
· Sponsor: NRG Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi)
· Sponsor: National Cancer Institute (NCI)
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Augusta Oncology Associates PC-D'Antignac — Augusta, Georgia (9.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Sickle Cell Disease
N/A
Observational 500 participants sought
Augusta University — Augusta, Georgia (9.2 mi)
· Sponsor: RTI International
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Solid Tumor, Advanced Solid Tumor
Phase 1
Interventional 238 participants sought
Augusta University — Augusta, Georgia (9.2 mi)
· Sponsor: NiKang Therapeutics, Inc.
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Parkinson Disease, Parkinson
Phase 2
Interventional 150 participants sought
Augusta University — Augusta, Georgia (9.2 mi)
· Sponsor: Neuron23 Inc.
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Orthopedic and Sports Medicine — Augusta, Georgia (9.2 mi)
· Sponsor: Exactech
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase
Phase 1, Phase 2
Interventional 330 participants sought
Georgia Cancer Center at Augusta University — Augusta, Georgia (9.2 mi)
· Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Huntington's Disease
N/A
Observational 35,000 participants sought
Georgia Health Sciences University — Augusta, Georgia (9.2 mi)
· Sponsor: CHDI Foundation, Inc.
Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
Multiple Myeloma, Autologous Stem Cell Transplantation
Phase 3
Interventional 172 participants sought
Wellstar MCG — Augusta, Georgia (9.2 mi)
· Sponsor: Augusta University
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 231 participants sought
Site Number - 1043 — Augusta, Georgia (9.2 mi)
· Sponsor: Immunovant Sciences GmbH
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Treatment Resistant Depression
N/A
Interventional 6,800 participants sought
Medical College of Georgia, Augusta University — Augusta, Georgia (9.2 mi)
· Sponsor: LivaNova
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Augusta University — Augusta, Georgia (9.2 mi)
· Sponsor: Novo Nordisk A/S
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Southeast Retina Center, P.C. — Augusta, Georgia (9.2 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Augusta, Georgia (9.2 mi)
· Sponsor: AstraZeneca
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Augusta Oncology Associates PC-D'Antignac — Augusta, Georgia (9.2 mi)
· Sponsor: SWOG Cancer Research Network